Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids

Annals of Pharmacotherapy

Volumn 41, Issue 5, 2007, Pages 857-860

  Ghulam, Asif ^a   Keen, Kate ^a   Tuleu, Catherine ^a,b   Wong, Ian Chi Kei ^a   Long, Paul F ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Department of Pharmaceutics ^*  (United Kingdom)

Author keywords

Compounding; Extemporaneous; Pediatrics; Preservatives; Stability; Vehicles

Indexed keywords

DRUG VEHICLE; METHYLCELLULOSE;

ARTICLE; BIOSAFETY; BIOTRANSFORMATION; CONTAINER; DILUTION; DRUG FORMULATION; DRUG QUALITY; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; IMMUNOCOMPROMISED PATIENT; MEDICAL LITERATURE; MEDICINE; MICROORGANISM; ORGANOLEPTIC PROPERTY; PEDIATRICS; PREMATURITY; PRIORITY JOURNAL; QUALITY CONTROL; RESEARCH; SHELF LIFE; SIMULATION; SYRUP;

ANTI-INFECTIVE AGENTS; BACTERIA; COLONY COUNT, MICROBIAL; DOSAGE FORMS; DRUG COMPOUNDING; DRUG STABILITY; EUROPE; HUMANS; METHYLCELLULOSE; PARABENS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PRESERVATIVES, PHARMACEUTICAL; SUCROSE; VEHICLES;

EID: 34248588479     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H611     Document Type: Article

References (11)

1. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000;320:79-82.
2. Brion F, Nunn A, Rieutord A. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr 2003;92:486-90.
3. Allen LV. The art and science of pharmaceutical compounding. 2nd ed. Washington, DC: APhA Publications, 2005:493.
4. Woods DJ. Formulation in practice, eMixt CD. 2nd ed. 2001. Pharminfotech, New Zealand. www.pharminfotech.co.nz/manual/Formulation/oral.htm (accessed 2007 Apr 3).
5. Nahata MC, Pai VB, Hipple TF. Pediatric drug formulations. 5th ed. Cincinnati, OH: Harvey Whitney Books, 2004:307.
6. Appendix XVID: C. Efficacy of antimicrobial preservation, D. Microbiological quality of pharmaceutical preparation. British Pharmacopoeia 2007. London: HMSO, 2007: A384-6.
7. Salgado AS, Rosa ML, Duarte MA, et al. Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations. Eur J Hosp Pharm Sci 2005;11:68-73.
8. Nunn AJ. Good pharmaceutical practices for extemporaneous dispensing. www.emea.europa.eu/pdfs/human/peg/822702en.pdf (accessed 2006 Dec 20).
9. Kirsch L. Extemporaneous quality. PDA J Pharm Sci Technol 2005;59:1-2.
10. European Commission. Medicines for Children. www.ec.europa.eu/enterprise/ pharmaceuticals/paediatrics/index Jitm (accessed 2006 Dec 19).
11. Long PF, Han J, Tuleu C, Wong IC-K. Microbiological tests on oral pediatric medicines - requirements for an improved pharmacopoeia monograph. Ann Pharmacother 2006;40:158-9. Epub 20 Dec 2005. DOI 10.1345/aph.1G349